Nelipepimut-S
Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1].
Product Specifications
CAS Number
160212-35-1
UNSPSC
12352209
Target
EGFR
Type
Peptides
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nelipepimut-s.html
Solubility
H2O
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@@H](NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CO)NC(CNC([C@@H](NC([C@H]([C@@H](C)CC)NC([C@@H](N)CCCCN)=O)=O)CC1=CC=CC=C1)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O
Molecular Formula
C50H78N10O11
Molecular Weight
995.21
References & Citations
[1]Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press) . 2020 Apr 3;12:69-75.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
Phase 3
Isoform
ErbB2/HER2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6320501-01 0.1 mL
MFAP4, CT (MFAP4, Microfibril-associated glycoprotein 4) (MaxLight 750)
Sign In for Pricing
View Details MBS6320501-02 5x 0.1 mL
MFAP4, CT (MFAP4, Microfibril-associated glycoprotein 4) (MaxLight 750)
Sign In for Pricing
View Details 
